NCT00003396View on ClinicalTrials.gov

Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions
LeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
Interventions
BIOLOGICAL

anti-thymocyte globulin

BIOLOGICAL

graft-versus-tumor induction therapy

DRUG

cyclophosphamide

DRUG

melphalan

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

radiation therapy

Trial Locations (1)

21201

Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore

All Listed Sponsors
collaborator

University of Maryland Greenebaum Cancer Center

OTHER

lead

University of Maryland, Baltimore

OTHER

NCT00003396 - Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter